BioCentury | Sep 16, 2020
Emerging Company Profile

Graphite launches with $45M series A to use CRISPR-Cas9 for targeted gene integration

...up in a legal battle between the Broad Institute of MIT and Harvard...
BioCentury | Sep 11, 2020
Politics, Policy & Law

Broad Institute holds its ground in CRISPR IP dispute

...decision on motions in the second major interference case involving CRISPR patents filed by the Broad Institute of MIT and Harvard...
...Inc. and CRISPR Therapeutics AG (NASDAQ:CRSP) have rights to the UC patents for therapeutic applications. Lauren Martz Broad Institute of MIT and Harvard University...
BioCentury | Aug 1, 2020
Tools & Techniques

Lurie winner and incoming Genentech R&D chief Aviv Regev looks to gene programs to untangle complex diseases

...landmark Nature study that profiled the transcriptomes of 18 dendritic cells. Regev’s lab at the Broad Institute of MIT and Harvard...
BioCentury | Jul 22, 2020
Emerging Company Profile

Jnana goes after metabolism-mediating proteins, gains Roche as partner

...and chemical biology at Harvard University and one of the founding core members of the Broad Institute of MIT and Harvard...
BioCentury | Jul 15, 2020
Product Development

Repurposing hopes for Tavalisse in COVID-19 breathe life into Rigel shares

...U.S. and Europe for adult chronic immune thrombocytopenia (ITP). Rigel also said of 3,713 compounds Broad Institute of MIT and Harvard...
BioCentury | Jul 10, 2020
Tools & Techniques

Precise base editing of mitochondrial DNA

...specificity, and there is no known mechanism for RNA entry into mitochondria. Liu, of The Broad Institute of MIT and Harvard...
...additional deaminases to feed their pipeline. Targets ND4 - NADH dehydrogenase subunit 4 Danielle Kopke, Staff Writer Broad Institute of MIT and Harvard University...
BioCentury | Jul 3, 2020
Translation in Brief

Tesla developing RNA therapeutic ‘microfactories’ for CureVac, plus CRISPR-directed RNA epigenetic modifications and Nucleix

...by CRISPR pioneer David Liu have generated Cas13-based tools for targeted RNA epigenetic modifications. The Broad Institute of MIT and Harvard...
...CRISPR-associated protein 13b METTL3 - methyltransferase like 3 METTL14 - Methyltransferase like 14 BioCentury Staff Bladder EpiCheck CureVac AG Broad Institute of MIT and Harvard Nucleix...
BioCentury | Jun 27, 2020
Translation in Brief

Regeneron enhances checkpoint therapy with CD28 bispecifics; plus NIH funds Alzheimer’s brain mapping, Genentech and more

...TEAD - TEA domain family member BioCentury Staff Regeneron Pharmaceuticals Inc. Genentech Inc. Roche Dana-Farber Cancer Institute Allen Institute National Institute on Aging Broad Institute of MIT and Harvard CD28 Prostate-specific...
BioCentury | Jun 6, 2020
Translation in Brief

Engineered bacteria for targeted bacterial killing; plus Cas12a base editors, base editing to restore hearing and more

...NIMA-interacting 1 TMC1 - Transmembrane channel-like-1 Danielle Kopke, Staff Writer PDAC University of Washington University of California San Diego Harvard University Broad Institute of MIT and Harvard Beth...
BioCentury | May 20, 2020
Deals

Mammoth, GSK to take CRISPR diagnostics beyond the centralized lab

...the diagnostic company formed around the gene editing technology from Feng Zhang’s lab at the Broad Institute of MIT and Harvard...
Items per page:
1 - 10 of 428
BioCentury | Sep 16, 2020
Emerging Company Profile

Graphite launches with $45M series A to use CRISPR-Cas9 for targeted gene integration

...up in a legal battle between the Broad Institute of MIT and Harvard...
BioCentury | Sep 11, 2020
Politics, Policy & Law

Broad Institute holds its ground in CRISPR IP dispute

...decision on motions in the second major interference case involving CRISPR patents filed by the Broad Institute of MIT and Harvard...
...Inc. and CRISPR Therapeutics AG (NASDAQ:CRSP) have rights to the UC patents for therapeutic applications. Lauren Martz Broad Institute of MIT and Harvard University...
BioCentury | Aug 1, 2020
Tools & Techniques

Lurie winner and incoming Genentech R&D chief Aviv Regev looks to gene programs to untangle complex diseases

...landmark Nature study that profiled the transcriptomes of 18 dendritic cells. Regev’s lab at the Broad Institute of MIT and Harvard...
BioCentury | Jul 22, 2020
Emerging Company Profile

Jnana goes after metabolism-mediating proteins, gains Roche as partner

...and chemical biology at Harvard University and one of the founding core members of the Broad Institute of MIT and Harvard...
BioCentury | Jul 15, 2020
Product Development

Repurposing hopes for Tavalisse in COVID-19 breathe life into Rigel shares

...U.S. and Europe for adult chronic immune thrombocytopenia (ITP). Rigel also said of 3,713 compounds Broad Institute of MIT and Harvard...
BioCentury | Jul 10, 2020
Tools & Techniques

Precise base editing of mitochondrial DNA

...specificity, and there is no known mechanism for RNA entry into mitochondria. Liu, of The Broad Institute of MIT and Harvard...
...additional deaminases to feed their pipeline. Targets ND4 - NADH dehydrogenase subunit 4 Danielle Kopke, Staff Writer Broad Institute of MIT and Harvard University...
BioCentury | Jul 3, 2020
Translation in Brief

Tesla developing RNA therapeutic ‘microfactories’ for CureVac, plus CRISPR-directed RNA epigenetic modifications and Nucleix

...by CRISPR pioneer David Liu have generated Cas13-based tools for targeted RNA epigenetic modifications. The Broad Institute of MIT and Harvard...
...CRISPR-associated protein 13b METTL3 - methyltransferase like 3 METTL14 - Methyltransferase like 14 BioCentury Staff Bladder EpiCheck CureVac AG Broad Institute of MIT and Harvard Nucleix...
BioCentury | Jun 27, 2020
Translation in Brief

Regeneron enhances checkpoint therapy with CD28 bispecifics; plus NIH funds Alzheimer’s brain mapping, Genentech and more

...TEAD - TEA domain family member BioCentury Staff Regeneron Pharmaceuticals Inc. Genentech Inc. Roche Dana-Farber Cancer Institute Allen Institute National Institute on Aging Broad Institute of MIT and Harvard CD28 Prostate-specific...
BioCentury | Jun 6, 2020
Translation in Brief

Engineered bacteria for targeted bacterial killing; plus Cas12a base editors, base editing to restore hearing and more

...NIMA-interacting 1 TMC1 - Transmembrane channel-like-1 Danielle Kopke, Staff Writer PDAC University of Washington University of California San Diego Harvard University Broad Institute of MIT and Harvard Beth...
BioCentury | May 20, 2020
Deals

Mammoth, GSK to take CRISPR diagnostics beyond the centralized lab

...the diagnostic company formed around the gene editing technology from Feng Zhang’s lab at the Broad Institute of MIT and Harvard...
Items per page:
1 - 10 of 428